{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:02Z","timestamp":1787016902392,"version":"build-2736575974"},"reference-count":23,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1136\/bjophthalmol-2012-301944","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T21:40:45Z","timestamp":1359754845000},"page":"796-800","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate"],"prefix":"10.1136","volume":"98","author":[{"given":"Koray","family":"Gumus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarper","family":"Karakucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Ertugrul","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Arda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse O","family":"Oner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2012-301944-1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00055735-199908000-00011","article-title":"The pathogenesis of pterygia","volume":"10","author":"Coroneo","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-301944-2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9394(99)00161-0","article-title":"Sun exposure and pterygium of the eye: a dose-response curve","volume":"128","author":"Threlfall","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-301944-3","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1167\/iovs.10-6673","article-title":"Activation of MAPK signaling pathway and NF- {kappa} B activation in pterygium and ipsilateral pterygium-free conjunctival specimens","volume":"52","author":"Torres","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2012-301944-4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/ijmm_00000149","article-title":"Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review)","volume":"23","author":"Detorakis","year":"2009","journal-title":"Int J Mol Med"},{"key":"key-10.1136\/bjophthalmol-2012-301944-5","first-page":"671","article-title":"Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells","volume":"41","author":"Di Girolamo","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2012-301944-6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00003226-199907000-00011","article-title":"Differential effects of epidermal growth factor and interleukin 6 on corneal epithelial cells and vascular endothelial cells","volume":"18","author":"Nakamura","year":"1999","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-301944-7","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2012-301944-8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1167\/iovs.10-5735","article-title":"The nuclear-factor kappaB pathway is activated in pterygium","volume":"52","author":"Siak","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2012-301944-9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00003226-200110000-00013","article-title":"Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia","volume":"20","author":"Lee","year":"2001","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-301944-10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.eye.6702495","article-title":"Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1","volume":"21","author":"Aspiotis","year":"2007","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2012-301944-11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0161-6420(00)00567-4","article-title":"Amniotic membrane trans- plantation after extensive removal of primary and recurrent pterygia","volume":"108","author":"Solomon","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2012-301944-12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/ICO.0b013e3181dc814e","article-title":"Effect of pterygia on refractive indices, corneal topography, and ocular aberrations","volume":"30","author":"Gumus","year":"2011","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-301944-13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":"Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia","volume":"22","author":"Jin","year":"2003","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-301944-14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/ceyr.25.1.17.9959","article-title":"Angiogenesis in pterygium: morphometric and immunohistochemical study","volume":"25","author":"Marcovich","year":"2002","journal-title":"Curr Eye Res"},{"key":"key-10.1136\/bjophthalmol-2012-301944-15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","article-title":"Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia","volume":"112","author":"Gebhardt","year":"2005","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2012-301944-16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.eye.6702433","article-title":"Endothelial progenitor cells in pterygium pathogenesis","volume":"21","author":"Lee","year":"2007","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2012-301944-17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","article-title":"Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors","volume":"95","author":"Peichev","year":"2000","journal-title":"Blood"},{"key":"key-10.1136\/bjophthalmol-2012-301944-18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ajo.2010.01.015","article-title":"Phase I study of subconjunctival ranibizumab in patients with primary pterygium undergoing pterygium surgery","volume":"149","author":"Galor","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-301944-19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713680903395273","article-title":"Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium","volume":"35","author":"Fallah","year":"2010","journal-title":"Curr Eye Res"},{"key":"key-10.1136\/bjophthalmol-2012-301944-20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICO.0b013e31818d382d","article-title":"Effect of subconjunctival bevacizumab on primary pterygium","volume":"28","author":"Teng","year":"2009","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-301944-21","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/ICO.0b013e3181d927b9","article-title":"The effect of subconjunctival ranibizumab on primary pterygium: a pilot study","volume":"29","author":"Mandalos","year":"2010","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-301944-22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000252980","article-title":"Preliminary results of subconjunctival bevacizumab in primary pterygium excision","volume":"43","author":"Razeghinejad","year":"2010","journal-title":"Ophthalmic Res"},{"key":"key-10.1136\/bjophthalmol-2012-301944-23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr Eye Res"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2012-301944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:42:10Z","timestamp":1601095330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2012-301944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,5,17]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1136\/bjophthalmol-2012-301944"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2012-301944","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}